Navigation Links
UC Davis scientists find new role for P53 genetic mutation -- initiation of prostate cancer
Date:6/7/2012

(SACRAMENTO, Calif.) A team of UC Davis investigators has found that a genetic mutation may play an important role in the development of prostate cancer. The mutation of the so-called p53 (or Tp53) gene was previously implicated in late disease progression, but until now has never been shown to act as an initiating factor. The findings may open new avenues for diagnosing and treating the disease.

The study was published online in the journal Disease Models & Mechanisms and will appear in the November 2012 print edition in an article titled, "Initiation of prostate cancer in mice by Tp53R270H: Evidence for an alternate molecular progression," and is available online.

"Our team found a molecular pathway to prostate cancer that differs from the current conventional wisdom of how the disease develops," said Alexander Borowsky, associate professor of pathology and laboratory medicine and principal investigator of the study. "With this new understanding, research can go in new directions to possibly develop new diagnostics and refine therapy."

Prostate cancer is the leading cancer diagnosis in men in the United States. Although it is curable in about 80 percent of men with localized disease, the rate is much lower if the cancer is highly virulent and has spread beyond the prostate gland.

The investigators developed a mouse model genetically engineered to have a mutation in the "tumor suppressor" gene, p53, specifically in the cells of the prostate gland. These mice were significantly more likely to develop prostate cancer than control mice without the mutation, and provided the first indication that the p53 mutation could be involved in the initiation of prostate cancer. They also note that the mutation of p53 in the prostate differs from loss or "knock-out" of the gene, which suggests that the mechanism is more complicated than simply a "loss of tumor suppression" and appears to involve an actively oncogenic function o
'/>"/>

Contact: Dorsey Griffith
dorsey.griffith@ucdmc.ucdavis.edu
916-734-9118
University of California - Davis Health System
Source:Eurekalert

Page: 1 2

Related biology news :

1. OU scientists and international team deciper the genetic code of the tomato
2. Scientists discover a new sensory organ in the chin of baleen whales
3. Scientists start explaining Fat Bastards vicious cycle
4. Scientists find gold-plated fossil solution
5. New study by WHOI scientists provides baseline measurements of carbon in Arctic Ocean
6. Novel discovery by NUS scientists paves the way for more effective treatment of cancers
7. Stanford scientists document fragile land-sea ecological chain
8. Using graphene, scientists develop a less toxic way to rust-proof steel
9. Scripps Florida scientists awarded $8.4 million grant to develop new anti-smoking treatments
10. Berkeley Lab scientists generate electricity from viruses
11. Scientists read the ash from the Icelandic volcano 2 years after its eruption
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... (May 23, 2013) A new report from ... for helping pupils engage in at least 60 minutes ... day. , No more than half of American youth ... of vigorous or moderate intensity physical activity daily, according ... "Because children are in school for nearly half of ...
(Date:5/23/2013)... Inside the natural history museums of the world are ... and beetles to flowers, mushrooms and grasses, all stacked, ... The rich and diverse collections could be critical to ... face of a growing human footprint if only ... project, brought to life with the help of a ...
(Date:5/23/2013)... reveal the interplay of brain chemicals which help us ... and BBSRC. , By changing the way neurons ... While these changes can affect the strength of a ... that response. , Lead author Alex Thiele, ... others, you can make yourself better heard by speaking ...
Breaking Biology News(10 mins):Schools should provide students with daily physical activity, IOM recommends 2CU-Boulder helps tap crowds to digitize museum records of bugs and plants 2CU-Boulder helps tap crowds to digitize museum records of bugs and plants 3CU-Boulder helps tap crowds to digitize museum records of bugs and plants 4
... consistent quality images, resulting in ... higher accuracy and better user experience, WALL, ... BKYI), a leader in finger-based biometric,identification and wireless public ... U.S. Patent and Trademark Office issued US patent,No. 7,359,553 ...
... A team of researchers led by scientists at Cold Spring ... that allow the pituitary glands of mice to grow even ... stem cells, these cells are distinct from those that fuel ... a novel way that the hormone-secreting gland may adapt, even ...
... University] Many of society,s most pressing problems ... drinking water, rooting out the biomarkers of diseases ... and nanoscale level. Such complex research is no longer ... disciplines, involving scientists with varied backgrounds and expertise. ...
Cached Biology News:BIO-key(R) Granted Image Identification System Patent for Award Winning Biometric Technology 2BIO-key(R) Granted Image Identification System Patent for Award Winning Biometric Technology 3Scientists find stem cells for the first time in the pituitary 2Scientists find stem cells for the first time in the pituitary 3Brown opens institute for molecular and nanoscale innovation 2
(Date:5/24/2013)... New York, NY (PRWEB) May 24, 2013 ... help the public protect themselves from the looming higher risk ... Cleaning Products published a new bed bug guideline. In the ... of bed bugs and avoiding them while traveling. ... why there is an increase of bed bug infestation during ...
(Date:5/24/2013)... 24, 2013 Senomyx , Inc. (NASDAQ: ... science technologies to discover, develop, and commercialize novel flavor ... , Ph.D., the Company,s Vice President, Biology and ... & Corporate Communications, will present an overview of Senomyx,s ... a.m. Eastern Time (7:25 a.m. Pacific Time) during the ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 Many factors ... and uptake or efflux transporters at the blood-tissue barrier. ... related to unbound fractions in the tissue rather than ... these disposition challenges is required to guide lead optimization, ... identify any species-dependent variables that may impact the likely ...
(Date:5/24/2013)... Vestiage, Inc. (stock symbol "VEST") a publicly ... and development, sales and marketing of premium branded ... that it is awarding exclusive Vestiage territories in ... Skin Illuminating Facial Care. Qualified applicants can request ... email to info(at)vestiageinc(dot)com and putting RELUMA in the ...
Breaking Biology Technology:Steps for Getting Rid of Bed Bugs without Using Chemicals and Avoiding Them While Traveling Enumerated by My Cleaning Products in Its Latest Post 2Steps for Getting Rid of Bed Bugs without Using Chemicals and Avoiding Them While Traveling Enumerated by My Cleaning Products in Its Latest Post 3SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE CITI 2013 GLOBAL CONSUMER CONFERENCE 2DMPK for Targeted Tissue Delivery: Solutions for the Most Challenging Part of Outsourcing, New Life Science Webinar Hosted by Xtalks 2Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 2Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 3Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 4Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 5
... in the Trial,s First Stage ... Achieved Objective Tumor Responses- ... Calif., Oct. 21 Peregrine,Pharmaceuticals, Inc. (Nasdaq: PPHM ), a ... today announced that updated preliminary data from the first,stage of its ...
... sales progress being made as distribution channel ... BioElectronics Corp. (BIEL),the maker of ActiPatch(R) Therapy, ... battery operated microchip delivering continuous pulse,therapy that ... it has,achieved additional distribution penetration into the ...
... Healthcare Providers, LEXINGTON, Mass., Oct. 21 - ... award, and is now accepting,nominations. Award recipients will ... have demonstrated true passion for their,profession and have ... of,patient care. Three winners whose stories reflect uncommon ...
Cached Biology Technology:Peregrine Pharmaceuticals Reports Progress in Its Phase II Trial of Bavituximab Plus Docetaxel in Patients With Advanced Breast Cancer 2Peregrine Pharmaceuticals Reports Progress in Its Phase II Trial of Bavituximab Plus Docetaxel in Patients With Advanced Breast Cancer 3Peregrine Pharmaceuticals Reports Progress in Its Phase II Trial of Bavituximab Plus Docetaxel in Patients With Advanced Breast Cancer 4BioElectronics Announces Significant Progress in Canadian and International Distribution 2Instrumentation Laboratory Announces 'Passion & Results' Awards Program 2